Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy

European Urology

Volumn 53, Issue 2, 2008, Pages 333-346

  Schlomm, Thorsten ^a   Näkel, Esther ^a   Lübke, Andreas ^a   Buness, Andreas ^b   Chun, Felix K H ^a   Steuber, Thomas ^a   Graefen, Markus ^a   Simon, Ronald ^a   Sauter, Guido ^a   Poustka, Annemarie ^b   Huland, Hartwig ^a   Erbersdobler, Andreas ^a   Sültmann, Holger ^b   Hellwinkel, Olaf J C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Degradation; Gene; Gene expression; Ischemia; Prostate cancer; RNA; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

AGED; BIOPSY; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSTATECTOMY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 37349082029     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.075     Document Type: Article

References (21)

1. Rhodes D.R., Barrette T.R., Rubin M.A., Ghosh D., and Chinnaiyan A.M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 62 (2002) 4427-4433
2. Brenton J.D., Carey L.A., Ahmed A.A., and Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 23 (2005) 7350-7360
3. Magee J.A., Araki T., Patil S., et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61 (2001) 5692-5696
4. Dhanasekaran S.M., Barrette T.R., Ghosh D., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 (2001) 822-826
5. LaTulippe E., Satagopan J., Smith A., et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62 (2002) 4499-4506
6. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
7. Singh D., Febbo P.G., Ross K., et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1 (2002) 203-209
8. Lapointe J., Li C., Higgins J.P., et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101 (2004) 811-816
9. Glinsky G.V., Glinskii A.B., Stephenson A.J., Hoffman R.M., and Gerald W.L. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 113 (2004) 913-923
10. Yu Y.P., Landsittel D., Jing L., et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22 (2004) 2790-2799
11. Luo J., Duggan D.J., Chen Y., et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61 (2001) 4683-4688
12. Welsh J.B., Sapinoso L.M., Su A.I., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61 (2001) 5974-5978
13. Spruessel A., Steimann G., Jung M., et al. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques 36 (2004) 1030-1037
14. Dash A., Maine I.P., Varambally S., et al. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 161 (2002) 1743-1748
15. Lin D.W., Coleman I.M., Hawley S., et al. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J Clin Oncol 24 (2006) 3763-3770
16. Schlomm T., Luebke A.M., Sültmann H., et al. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Int J Oncol 27 (2005) 713-721
17. Pfaffl M.W., Tichopad A., Prgomet C., and Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26 (2004) 509-515
18. Adamson E., de Belle I., Mittal S., et al. Egr1 signaling in prostate cancer. Cancer Biol Ther 2 (2003) 617-622
19. Cursio R., Filippa N., Miele C., et al. Fas ligand expression following normothermic liver ischemia-reperfusion. J Surg Res 125 (2005) 30-36
20. Chkhotua A.B., Abendroth D., Froeba G., and Schelzig H. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int 19 (2006) 72-77
21. Neudeck H., Oei S.L., Stiemer B., Hopp H., and Graf R. Binding of antibodies against high and low molecular weight cytokeratin proteins in the human placenta with special reference to infarcts, proliferation and differentiation processes. Histochem J 29 (1997) 419-430